Lion Biotechnologies, Inc. reported raising $100 Million in an initial SEC Form D filing, from an offering of $100 Million
Amount Raised
$100 Million
Round Type
Venture
San CarlosManufacturingBiotechnologyHealth CareTherapeuticsQuick answer
Iovance Biotherapeutics raised $100 Million in a funding round, dated June 15, 2016. Iovance Biotherapeutics is based in San Carlos, California, United States.
- How much did Iovance Biotherapeutics raise?
- Iovance Biotherapeutics raised $100 Million in a funding round on June 15, 2016.
- What does Iovance Biotherapeutics do?
- Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.
- Where is Iovance Biotherapeutics based and how big is it?
- Iovance Biotherapeutics is based in San Carlos, California, United States. Fundz records about 804 employees.
- Who are the decision-makers at Iovance Biotherapeutics?
- Fundz holds 1 contact at Iovance Biotherapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Manufacturing around the same time
Companies in the same sectors as Iovance Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- AbbVie Inc. raised $3.8B on May 9, 2016.
- RIVANNA raised $170K on July 20, 2016.
- Amicus Therapeutics raised $4.7M (Seed) on July 19, 2016.
- Immunome Inc. raised $5.1M on July 14, 2016.
- Oragenics raised $4.7M (Seed) on July 13, 2016.
- Rezolute raised $5.4M on July 13, 2016.
Who to call at Iovance Biotherapeutics, and when
A new round usually means Iovance Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Iovance Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Iovance Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Iovance Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Iovance Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Iovance Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.